TCM Matrine Inducescell Arrest and Apoptosis with Recovery Expression of the Hepato-specific MiR122a in Human Hepatocellular CarcinomaHep G2cell Line

Overview

Journal Int J Clin Exp Med

Specialty General Medicine

Date 2015 Aug 27

PMID 26309553

Citations 3

Authors

Wuyuan Zhou

Xiang Xu

Jie Gao

Pengfei Sun

Lei Li

Xuetao Shi

Jie Li

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) accounts for 80% to 90% of liver cancers and it is one of the most prevalent carcinomas throughout the world. Traditional chemotherapy is often developed chemoresistance HCC patients.Matrine is an active component oftraditional Chinese medicine (TCM) and is a promising alternative HCC drug. In this study, the therapeutic effects and the underlying molecular mechanisms of matrine on the human HCC cell lineHep G2 were investigated. High dosage of matrine (1.0 mg/mL) could significantly (P < 0.05) inhibit cell proliferation by 48.39 ± 3.32%, under which cell shrinkage and disruption were observed. Flow cytometry assay showed that the proportion of G1/G0 cells significantly increased, while that of S and G2/M cells significantly decreased after treatment of matrinefor 48 h. These results indicated that cell arrest by matrine appeared. Up-regulation of the hepato-specific miR122a followed by down expression of its targetcyclin G1 (CG1) gene by low concentration of matrine (0.2 mg/mL) was detected using was observed using quantitative real-time PCR, immunohistochemistry (IHC) and western blot assays. In conclusion, matrineinducescell arrest and apoptosis with recovery expression of the hepato-specific miR122a in human hepatocellular carcinoma Hep G2 cell line.

Citing Articles

Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy.

Li Z, Wang N, Yue T, Liu L Transl Cancer Res. 2022; 9(2):786-794.

PMID: 35117424 PMC: 8799069. DOI: 10.21037/tcr.2019.12.11.

Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma.

Xi S, Minuk G World J Hepatol. 2018; 10(11):799-806.

PMID: 30533181 PMC: 6280158. DOI: 10.4254/wjh.v10.i11.799.

Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.

Liao X, Tao L, Liu J, Gu Y, Xie J, Chen Y Cancer Cell Int. 2018; 17:124.

PMID: 29299027 PMC: 5745706. DOI: 10.1186/s12935-017-0495-6.

References

Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber H . Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol. 2003; 64(2):382-94. DOI: 10.1124/mol.64.2.382. View

Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu C . Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007; 67(13):6092-9. DOI: 10.1158/0008-5472.CAN-06-4607. View

Danielsen T, Hvidsten M, Stokke T, Solberg K, Rofstad E . Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells. Br J Cancer. 1998; 78(12):1547-58. PMC: 2063247. DOI: 10.1038/bjc.1998.722. View

Wang Y, Peng C, Zhang G, Liu Y, Li H, Shan J . [Study on invasion and metastasis related factors in differentiation of SMMC-7721 cells induced by matrine]. Zhong Yao Cai. 2003; 26(8):566-9. View

Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q . Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology. 2006; 229(3):245-52. DOI: 10.1016/j.tox.2006.10.020. View

Zhang J, Zhang M, Zhou J, Liu F, Zhou B, Xie W . Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol Sin. 2001; 22(2):183-6. View

Ma L, Wen S, Zhan Y, He Y, Liu X, Jiang J . Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med. 2008; 74(3):245-51. DOI: 10.1055/s-2008-1034304. View

Zhang L, Jiang J, Tam J, Zhang Y, Liu X, Xu X . Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res. 2001; 25(9):793-800. DOI: 10.1016/s0145-2126(00)00145-4. View

Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar C . The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001; 18(4):767-73. DOI: 10.3892/ijo.18.4.767. View

10.

Han Y, Zhang S, Wu J, Yu K, Zhang Y, Yin L . Matrine induces apoptosis of human multiple myeloma cells via activation of the mitochondrial pathway. Leuk Lymphoma. 2010; 51(7):1337-46. DOI: 10.3109/10428194.2010.488708. View

11.

Zhang S, Li L, Lu F . [Mortality of primary liver cancer in China from 1990 through 1992]. Zhonghua Zhong Liu Za Zhi. 2002; 21(4):245-9. View

12.

Wu P, Dugoua J, Eyawo O, Mills E . Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res. 2009; 28:112. PMC: 3225807. DOI: 10.1186/1756-9966-28-112. View

13.

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View

14.

Wang X, Ongkeko W, Chen L, Yang Z, Lu P, Chen K . Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology. 2010; 52(2):528-39. DOI: 10.1002/hep.23692. View

15.

Efferth T, Li P, Konkimalla V, Kaina B . From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007; 13(8):353-61. DOI: 10.1016/j.molmed.2007.07.001. View

16.

Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z . MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett. 2011; 310(2):160-9. DOI: 10.1016/j.canlet.2011.06.027. View

17.

Llovet J, Bruix J . Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003; 37(2):429-42. DOI: 10.1053/jhep.2003.50047. View

18.

Ooi L, Wang H, Luk C, Ooi V . Anticancer and antiviral activities of Youngia japonica (L.) DC (Asteraceae, Compositae). J Ethnopharmacol. 2004; 94(1):117-22. DOI: 10.1016/j.jep.2004.05.004. View

19.

Li C, Zhu Y, Zhang F, Fu L, Li X, Cheng Y . Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J Gastroenterol. 2005; 11(3):426-8. PMC: 4205354. DOI: 10.3748/wjg.v11.i3.426. View

20.

Avila M, Berasain C, Sangro B, Prieto J . New therapies for hepatocellular carcinoma. Oncogene. 2006; 25(27):3866-84. DOI: 10.1038/sj.onc.1209550. View